Browse catalog Tailored lists Find your matches Funders Programs

Investors Advisory Insights

DeepTech 2026 Playbook Request access

Home
/Investors
/Biotech
/Lumira Ventures

LV

Lumira Ventures

Pure DeepTechToronto, CanadaActiveWebsite LinkedIn

Stage FocusSeed, Series A, Series B+

GeographyUS, Canada

TypeVC

Last Activity2026

Industry Focus

Industries

BiotechMedtechRoboticsNeurotech

Investor TypeDeepTech Purist

ExposureMostly DeepTech Investments

Bio

Lumira Ventures is a life sciences venture capital firm headquartered in Toronto, with additional offices in Montreal, Vancouver and Boston. The firm traces to a 2007 management buyout of MDS Capital, and has since raised Fund II (C$121M, 2012), Fund III (C$178M, 2018) and Fund IV (US$222M / C$295M, 2021), plus strategic funds with Merck and Angelini, and has announced a first closing of Fund V. I...

Notable Investments

A

Aurinia Pharmaceuticals

F

Fusion Pharmaceuticals

C

Contraline

H

HistoSonics

N

Nervonik

B

Bardy Diagnostics

F

Forbius

C

Corus Pharmaceuticals

E

Edesa Biotech

E

ESSA Pharmaceuticals

E

Endotronix

S

Sound Blade Medical

Similar Funds

Dynamk Capital

New York, United States

Pure DeepTechBiotechMedtechHardwareSeedSeries A

Genesys Capital

Toronto, Canada

Pure DeepTechBiotechMedtechRoboticsSeedSeries A

MBX Capital

New York, United States

Pure DeepTechBiotechMedtechRoboticsPre-SeedSeed

Navigare Ventures

Stockholm, Sweden

Pure DeepTechBiotechSemiconductorsAdvanced MaterialsSeedSeries A

Prospect Venture Partners

Menlo Park, USA

Pure DeepTechBiotechMedtechRoboticsSeedSeries A

Red Tree Venture Capital

United States

Pure DeepTechBiotechNeurotechMedtechSeedSeries A

Work at Lumira Ventures? Claim this page

Pricing Insights Tailored lists

Privacy Policy Terms of Service

© 2026 Joltoo. All rights reserved.